Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients
about
AT2 receptor activities and pathophysiological implicationsInsulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulatorsUpregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic ratsAT2 Receptors: Potential Therapeutic Targets for Hypertension.A nonpeptide angiotensin II type 2 receptor agonist prevents renal inflammation in early diabetes.The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressureAT2 receptors: beneficial counter-regulatory role in cardiovascular and renal functionRationale for combining a direct renin inhibitor with other renin- angiotensin system blockers. Focus on aliskiren and combinations.Microvascular vasodilator properties of the angiotensin II type 2 receptor in a mouse model of type 1 diabetes.Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease.Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats.Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.Deciphering the nuclear bile acid receptor FXR paradigm.Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats.Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease.Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment.Effects of recombinant human erythropoietin on resistance artery endothelial function in stage 4 chronic kidney disease.The frail renin-angiotensin system.Arterial stiffness in insulin resistance: the role of nitric oxide and angiotensin II receptorsRenal nitric oxide synthase and antioxidant preservation in Cyp1a1-Ren-2 transgenic rats with inducible malignant hypertension.FXR an emerging therapeutic target for the treatment of atherosclerosisAngiotensin II type-2 receptor-specific effects on the cardiovascular system.Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure.The angiotensin II type 2 receptor in cardiovascular disease.New insights into insulin action and resistance in the vasculature.Blood pressure and renal hemodynamic effects of angiotensin fragments.Angiotensin II and the vascular phenotype in hypertension.Angiotensin receptor modulation and cardiovascular remodeling.Angiotensin II type 2 receptor agonists: where should they be applied?G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Hypoxia-inducible factor-1α in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-γ-angiotensin II receptor type 1 axis.ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery.FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells.Angiotensin Receptor Expression and Vascular Endothelial Dysfunction in Obstructive Sleep Apnea.Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease.The Effect of a Non-peptide Angiotensin II type 2 receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome.Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome.
P2860
Q26829592-417C5111-DBF4-4942-A50C-4851460956AAQ28081458-AF612BC2-38C1-4F99-BB78-A55C705C6B06Q28580814-343C75D6-8A6A-47FE-81FF-CBF2BE62624CQ30275852-5CE69C36-17F1-43CD-81D5-2EF61D2D29CFQ30300953-CE8E2B47-D249-42D3-B640-DEC9E80C177FQ30414541-43FD5B2B-EC33-410C-9BE6-178BF4197435Q30415577-35C8C363-F365-462B-A96E-315FCA8CA2A6Q30452640-BD133C67-7F94-41B0-B008-285A7A2CC067Q30843430-C03E01E8-3253-4993-B3D7-FDCF37CFCB35Q33496583-81017C9F-AE68-4D42-9354-240EB2339B76Q33685969-5FF71173-BE39-4D8F-8775-0DD1569960F7Q34543485-6988B292-C4DE-4F20-B389-43CFCFE1B6AFQ34626518-A4F5A2FD-CDFA-4D5F-AD51-825D02131F59Q35601958-F3BAABB0-7841-4BE7-9AFA-9873B26092CEQ36145170-E797D720-1FCB-40F8-A4F2-47F74E351342Q36548151-B26B36FA-6DC1-4E9A-9A53-8F219A40D44BQ36824720-EF197D54-6E31-4D64-9791-0FB338B8F561Q37150747-4659B58A-1927-4FCC-ADBB-2ABB01EAC467Q37167494-77B00B31-A3E9-4975-A5FD-DDC059B963B9Q37172395-CA7AA4CD-0559-4999-9DE9-E196562D9040Q37334984-FAF83D0F-D64E-46FF-9DA2-2D9630AFAE74Q37339329-202D12C3-DAEA-4602-A64D-1C75324D2AB0Q37416298-109403B1-10DB-45FC-8E36-7A0180729181Q37622575-A6B31A88-9360-4C41-B79A-14D2EAB74005Q37707789-CEC4C0EA-213E-4062-BB36-B0BB88A6BFFEQ37853834-56CB4FE4-95C1-4CC4-8CE5-C96824C862F1Q37859447-22EEF6DB-A71A-48C7-B65F-26F9BCA59064Q37924418-940109FF-90BC-4AD0-A958-774DF7935BFCQ37986143-85660203-4C3A-4DD9-936F-DEB7F8D4DA1FQ38093493-69320872-87E6-486C-9264-CD0C1BFCA805Q38217456-5A012EFB-28D9-44AB-960B-BE2BA70D481DQ41908818-5D000E2E-1089-4A69-9787-B0DDCB3E5A35Q45268057-402D4E7B-1504-43BB-BDA5-AE82A90C308AQ45277710-C53E5D74-C79D-48D3-96B7-1C1A19A09648Q46897927-0EA6D7DB-CC69-4F1D-B098-A000DC7D934DQ47673156-FB5E0256-6E57-45B0-A693-737E630F8AB7Q47734987-84F73372-9DB1-47E3-98CD-733037E9E404Q47752010-124CDE39-8745-441E-8971-6A156F62701BQ55403020-3C3428A1-D98E-4DFF-BD0F-D8A4131E2C92
P2860
Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@ast
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@en
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@en-gb
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@nl
type
label
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@ast
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@en
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@en-gb
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@nl
prefLabel
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@ast
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@en
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@en-gb
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@nl
P921
P1433
P1476
Angiotensin type 2 receptor in ...... diabetic hypertensive patients
@en
P2093
Ernesto L Schiffrin
Rhian M Touyz
P304
P356
10.1161/01.HYP.0000253968.95136.B8
P407
P577
2006-12-11T00:00:00Z